Wed, May 6, 2020

Ed Arce Maintained (AKBA) at Strong Buy with Increased Target to $17 on, May 6th, 2020

Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Increased Target from $16 to $17 on, May 6th, 2020.

Ed has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Chad Messer of "Needham" Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 5th, 2020


Similar Stocks and Investing Publications